Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers

Carcinogenesis

Volumn 32, Issue 9, 2011, Pages 1366-1371

  Yuan, Jian Min ^a,b   Knezevich, Aleksandar D ^a   Wang, Renwei ^a   Gao, Yu Tang ^c   Hecht, Stephen S ^a   Stepanov, Irina ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c SHANGHAI CANCER INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; GLUCURONIDE; NITROSONORNICOTINE;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; CIGARETTE SMOKING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DETOXIFICATION; ESOPHAGUS CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; URINALYSIS; URINE LEVEL;

EID: 80052426180     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr125     Document Type: Article

References (42)

1. Holmes, R.S. et al. (2007) Epidemiology and pathogenesis of esophageal cancer. Semin. Radiat. Oncol., 17, 2-9.
2. International Agency for Research on Cancer. (1986) Tobacco Smoking. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. IARC Scientific Publications, Lyon.
3. International Agency for Research on Cancer. (2004) Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. IARC Scientific Publications, Lyon.
4. Fan, Y. et al. (2008) Alcohol, tobacco, and diet in relation to esophageal cancer: the shanghai cohort study. Nutr. Cancer, 60, 354-363.
5. Vineis, P. et al. (2004) Tobacco and cancer: recent epidemiological evidence. J. Natl Cancer Inst., 96, 99-106.
6. Gammon, M.D. et al. (1997) Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J. Natl Cancer Inst., 89, 1277-1284.
7. U.S. Department of Health and Human Services. (1989) Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General 1989. US Department of Health and Human Services, Public Health Service, Rockville, MD.
8. Yuan, J.M. et al. (2001) Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China. Cancer Epidemiol. Biomarkers Prev., 10, 767-773.
9. Hoffmann, D. et al. (1990) Advances in tobacco carcinogenesis. In Cooper,C.S.Grover,P.L. (eds.) Handbood of Experimental Pharmacology. Springer-Verlag, Heidelberg, Germany, pp. 63-102.
10. Hecht, S.S. et al. (1989) The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv., 8, 273-294.
11. Hecht, S.S. (1998) Biochemistry, biology, and carcinogenicity of tobaccospecific N-nitrosamines. Chem. Res. Toxicol., 11, 559-603.
12. Hecht, S.S. et al. (1986) Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res., 46, 4162-4166.
13. International Agency for Research on cancer. (2007) Smokeless Tobacco and Tobacco-Specific Nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Scientific Publications, Lyon.
14. Stepanov, I. et al. (2005) Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users. Cancer Epidemiol. Biomarkers Prev., 14, 885-891.
15. Yuan, J.M. et al. (2009) Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res., 69, 2990-2995.
16. Church, T.R. et al. (2009) A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol. Biomarkers Prev., 18, 260-266.
17. Ross, R.K. et al. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, 943-946.
18. Yuan, J.M. et al. (1996) Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA, 275, 1646-1650.
19. Porubin, D. et al. (2007) Endogenous formation of N'-nitrosonornicotine in F344 rats in the presence of some antioxidants and grape seed extract. J. Agric. Food Chem., 55, 7199-7204.
20. Stepanov, I. et al. (2008) Detection and quantitation of N'-nitrosonornicotine in human toenails by liquid chromatography-electrospray ionization-tandem mass spectrometry. Cancer Epidemiol. Biomarkers Prev., 17, 945-948.
21. Stepanov, I. et al. (2009) Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer Res., 69, 8236-8240.
22. Stepanov, I. et al. (2008) Extensive metabolic activation of the tobaccospecific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers. Cancer Epidemiol. Biomarkers Prev., 17, 1764-1773.
23. Stepanov,I. et al. (2006) Uptake of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by Moldovan children. Cancer Epidemiol. Biomarkers Prev., 15, 7-11.
24. Hecht,S.S. et al. (1999) Quantitation of urinary metabolites of a tobaccospecific lung carcinogen after smoking cessation. Cancer Res., 59, 590-596.
25. Winer, B.J. (1971) Statistical Principles in Experimental Design. McGraw-Hill, New York, NY.
26. Breslow, N.E. et al. (1980) Statistical Methods in Cancer Research. Volume 1. The Analysis of Case-Control Studies. IARC Scientific Publication, Lyon.
27. Wu, W. et al. (2005) Determination of carcinogenic tobacco-specific nitrosamines in mainstream smoke from U.S.-brand and non-U.S.-brand cigarettes from 14 countries. Nicotine Tob. Res., 7, 443-451.
28. Carmella, S.G. et al. (1997) Evidence for endogenous formation of tobaccospecific nitrosamines in rats treated with tobacco alkaloids and sodium nitrite. Carcinogenesis, 18, 587-592.
29. Bartsch, H. et al. (1989) Human exposure to endogenous N-nitroso compounds: quantitative estimates in subjects at high risk for cancer of the oral cavity, oesophagus, stomach and urinary bladder. Cancer Surv., 8, 335-362.
30. Mirvish, S.S. (1995) Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett., 93, 17-48.
31. Stepanov, I. et al. (2006) Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob. Res., 8, 309-313.
32. Stepanov, I. et al. (2009) Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine Tob. Res., 11, 99-105.
33. Bartsch, H. et al. (1988) Inhibitors of endogenous nitrosation. Mechanisms and implications in human cancer prevention. Mutat. Res., 202, 307-324.
34. Chen, G. et al. (2008) Glucuronidation of tobacco-specific nitrosamines by UGT2B10. Drug Metab. Dispos., 36, 824-830.
35. Murphy, S.E. et al. (1990) Comparative metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured F344 rat oral tissue and esophagus. Cancer Res., 50, 4685-4691.
36. Murphy, S.E. et al. (2000) Specificity of cytochrome P450 2A3-catalyzed alpha-hydroxylation of N'-nitrosonornicotine enantiomers. Drug Metab. Dispos., 28, 1263-1266.
37. Gao, Y.T. et al. (1994) Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int. J. Cancer, 58, 192-196.
38. Castellsague, X. et al. (1999) Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int. J. Cancer, 82, 657-664.
39. Steevens, J. et al. (2010) Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut, 59, 39-48.
40. International Agency for Research on Cancer. (1988) Alcohol Drinking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Scientific Publications, Lyon.
41. Poschl, G. et al. (2004) Alcohol and cancer. Alcohol Alcohol, 39, 155-165.
42. Squier, C.A. (1986) Penetration of nicotine and nitrosonornicotine across porcine oral mucosa. J. Appl. Toxicol., 6, 123-128.